Cambridge Investment Research Advisors’s Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index GSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-95,622
Closed -$2M 3279
2022
Q3
$2M Buy
+95,622
New +$2.15M 0.01% 1032
2022
Q2
Sell
-25,916
Closed -$603K 3293
2022
Q1
$603K Buy
+25,916
New +$538K ﹤0.01% 1954
2018
Q4
Sell
-19,647
Closed -$347K 2367
2018
Q3
$347K Buy
19,647
+556
+3% +$9.27K ﹤0.01% 1702
2018
Q2
$332K Buy
+19,091
New +$321K ﹤0.01% 1662

Other funds holding GSP

Cambridge Investment Research Advisors's GSP Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index (GSP) in Q4 2022, closing a stake of 95,622 shares — an estimated $2M sold.

Cambridge Investment Research Advisors first reported a position in GSP in Q2 2018 and held it in 4 quarters. The position peaked at $2M in Q3 2022. 15 funds tracked by Wall St. Rank hold GSP as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 95,622 Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index shares in Q4 2022, an estimated $2M.
  • Cambridge Investment Research Advisors first reported a position in Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index in Q2 2018 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index position peaked at $2M in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.